Xue Hou
Minzu University of China(CN)Sun Yat-sen University(CN)Henan University of Technology(CN)Guangdong Academy of Medical Sciences(CN)Sun Yat-sen University Cancer Center(CN)Viva Biotech (China)(CN)State Key Laboratory of Oncology in South China
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy(2016)1,161 cited
- → Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials(2018)500 cited
- → EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy(2014)382 cited
- → RETRACTED ARTICLE: N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1(2019)219 cited
- → Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant(2024)140 cited
- → Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations(2014)